CLINICAL GENOTYPING AND EFFICACY OUTCOMES: EXPLORATORY BIOMARKER DATA FROM THE PHASE II ABIGAIL STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)

臺大醫院-內科部;Pallaud, C.C.PallaudReck, M.M.ReckJuhasz, E.E.JuhaszSzima, B.B.SzimaYu, C.C.YuBurdaeva, O.O.BurdaevaOrlov, S.S.OrlovScherer, S. J.S. J.SchererArcher, V.V.ArcherMok, T. S. K.T. S. K.Mok2014-02-142018-07-112014-02-142018-07-112012http://ntur.lib.ntu.edu.tw//handle/246246/25915682 bytestext/html[SDGs]SDG3CLINICAL GENOTYPING AND EFFICACY OUTCOMES: EXPLORATORY BIOMARKER DATA FROM THE PHASE II ABIGAIL STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)http://ntur.lib.ntu.edu.tw/bitstream/246246/259156/1/index.html